Patents by Inventor Manuel A. Vega Zepeda

Manuel A. Vega Zepeda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immediate Release Abuse-Deterrent Granulated Dosage Forms
    Publication number: 20170143637
    Abstract: Described are immediate release oral dosage forms that contain abuse-deterrent features. In particular, the disclosed dosage forms provide deterrence of abuse by ingestion of multiple individual doses. In addition, the disclosed dosage forms provide protection from overdose in the event of accidental or intentional ingestion of multiple individual doses.
    Type: Application
    Filed: February 2, 2017
    Publication date: May 25, 2017
    Inventors: Dinesh K. Haswani, Derek V. Moe, Victoria A. O'Neill, Randal A. Seburg, Manuel A. Vega Zepeda
  • Abuse resistant drug formulation
    Patent number: 9572803
    Abstract: A pharmaceutical composition may include a coated particulate which may include at least one active pharmaceutical ingredient, particularly one susceptible to abuse by an individual. The coated particles may include a fat/wax and have improved controlled release and/or crush resistance. Method of making these coated particulate and dosage forms therewith are also described.
    Type: Grant
    Filed: December 27, 2012
    Date of Patent: February 21, 2017
    Assignee: Cima Labs Inc.
    Inventors: Walid A. Habib, Ehab Hamed, Manuel A. Vega Zepeda
  • Immediate Release Abuse-Deterrent Granulated Dosage Forms
    Publication number: 20160317457
    Abstract: Described are immediate release oral dosage forms that contain abuse-deterrent features. In particular, the disclosed dosage forms provide deterrence of abuse by ingestion of multiple individual doses. In addition, the disclosed dosage forms provide protection from overdose in the event of accidental or intentional ingestion of multiple individual doses.
    Type: Application
    Filed: July 14, 2016
    Publication date: November 3, 2016
    Inventors: Dinesh K. Haswani, Derek V. Moe, Victoria A. O'Neill, Randal A. Seburg, Manuel A. Vega Zepeda
  • Abuse-resistant formulations
    Patent number: 9474721
    Abstract: The disclosure relates to a sustained-release oral dosage form for once-a-day administration comprising a matrix containing a viscosity modifier and coated granules containing hydromorphone. The dosage form can have a release profile such that 16 hours following administration, less than about 85 percent of the hydromorphone is released. In addition, the dosage form may have alcohol and/or crush resistance.
    Type: Grant
    Filed: June 5, 2014
    Date of Patent: October 25, 2016
    Assignee: Cima Labs Inc.
    Inventors: Ehab Hamed, Manuel A. Vega Zepeda
  • ABUSE-DETERRENT DOSAGE FORMS
    Publication number: 20160256392
    Abstract: Described are oral dosage forms that contain abuse-deterrent features and that contain a matrix with gelling polymer and disintegrant, with particular examples including immediate release dosage forms that contain a drug that is commonly susceptible to abuse.
    Type: Application
    Filed: July 17, 2014
    Publication date: September 8, 2016
    Inventors: Dinesh K. HASWANI, Derek V MOE, Victoria A. O'NEILL, Manuel A. VEGA ZEPEDA
  • IMMEDIATE RELEASE ABUSE-DETERRENT GRANULATED DOSAGE FORMS
    Publication number: 20160250203
    Abstract: Described are immediate release oral dosage forms that contain abuse-deterrent features. In particular, the disclosed dosage forms provide deterrence of abuse by ingestion of multiple individual doses. In addition, the disclosed dosage forms provide protection from overdose in the event of accidental or intentional ingestion of multiple individual doses.
    Type: Application
    Filed: October 29, 2014
    Publication date: September 1, 2016
    Inventors: Dinesh K. HASWANI, Derek V MOE, Victoria A. O'NEILL, Manuel A. VEGA ZEPEDA
  • Abuse resistant drug formulation
    Patent number: 9216176
    Abstract: A pharmaceutical composition may include a coated particulate which may include at least one active pharmaceutical ingredient, particularly one susceptible to abuse by an individual. The coated particles may include a fat/wax and have improved controlled release and/or crush resistance. Method of making these coated particulate and dosage forms therewith are also described.
    Type: Grant
    Filed: May 18, 2015
    Date of Patent: December 22, 2015
    Assignee: Cima Labs Inc.
    Inventors: Walid A. Habib, Ehab Hamed, Manuel A. Vega Zepeda
  • Abuse Resistant Drug Formulation
    Publication number: 20150250730
    Abstract: A pharmaceutical composition may include a coated particulate which may include at least one active pharmaceutical ingredient, particularly one susceptible to abuse by an individual. The coated particles may include a fat/wax and have improved controlled release and/or crush resistance. Method of making these coated particulate and dosage forms therewith are also described.
    Type: Application
    Filed: May 18, 2015
    Publication date: September 10, 2015
    Inventors: Walid A. Habib, Ehab Hamed, Manuel A. Vega Zepeda
  • Abuse Resistant Drug Formulation
    Publication number: 20150250781
    Abstract: A pharmaceutical composition may include a coated particulate which may include at least one active pharmaceutical ingredient, particularly one susceptible to abuse by an individual. The coated particles may include a fat/wax and have improved controlled release and/or crush resistance. Method of making these coated particulate and dosage forms therewith are also described.
    Type: Application
    Filed: May 18, 2015
    Publication date: September 10, 2015
    Inventors: Walid A. Habib, Ehab Hamed, Manuel A. Vega Zepeda
  • Immediate Release Abuse-Deterrent Granulated Dosage Forms
    Publication number: 20150118295
    Abstract: Described are oral dosage forms that contain abuse-deterrent features and that contain core-shell polymers that include an active pharmaceutical ingredient, with particular examples including immediate release dosage forms that contain a drug that is commonly susceptible to abuse.
    Type: Application
    Filed: September 12, 2014
    Publication date: April 30, 2015
    Inventors: Dinesh K. Haswani, Derek V. Moe, Victoria A. O'Neill, Manuel A. Vega Zepeda
  • Immediate Release Abuse-Deterrent Granulated Dosage Forms
    Publication number: 20150118300
    Abstract: Described are oral dosage forms that contain abuse-deterrent features and that contain core-shell polymers that include an active pharmaceutical ingredient, with particular examples including immediate release dosage forms that contain a drug that is commonly susceptible to abuse.
    Type: Application
    Filed: July 17, 2014
    Publication date: April 30, 2015
    Inventors: Dinesh K. Haswani, Derek V. Moe, Victoria A. O'Neill, Manuel A. Vega Zepeda
  • Immediate Release Abuse-Deterrent Granulated Dosage Forms
    Publication number: 20150118303
    Abstract: Described are immediate release oral dosage forms that contain abuse-deterrent features. In particular, the disclosed dosage forms provide deterrence of abuse by ingestion of multiple individual doses. In addition, the disclosed dosage forms provide protection from overdose in the event of accidental or intentional ingestion of multiple individual doses.
    Type: Application
    Filed: November 12, 2014
    Publication date: April 30, 2015
    Inventors: Dinesh K. Haswani, Derek V. Moe, Victoria A. O'Neill, Manuel A. Vega Zepeda
  • Immediate Release Abuse-Deterrent Granulated Dosage Forms
    Publication number: 20150118301
    Abstract: Described are oral dosage forms that contain abuse-deterrent features and that contain core-shell polymers that include an active pharmaceutical ingredient, with particular examples including immediate release dosage forms that contain a drug that is commonly susceptible to abuse.
    Type: Application
    Filed: September 4, 2014
    Publication date: April 30, 2015
    Inventors: Dinesh K. Haswani, Derek V. Moe, Victoria A. O'Neill, Manuel A. Vega Zepeda
  • Immediate Release Abuse-Deterrent Granulated Dosage Forms
    Publication number: 20150118302
    Abstract: Described are immediate release oral dosage forms that contain abuse-deterrent features. In particular, the disclosed dosage forms provide deterrence of abuse by ingestion of multiple individual doses. In addition, the disclosed dosage forms provide protection from overdose in the event of accidental or intentional ingestion of multiple individual doses.
    Type: Application
    Filed: October 29, 2014
    Publication date: April 30, 2015
    Inventors: Dinesh K. Haswani, Derek V. Moe, Victoria A. O'Neill, Manuel A. Vega Zepeda
  • Abuse-Resistant Formulations
    Publication number: 20140294953
    Abstract: The disclosure relates to a sustained-release oral dosage form for once-a-day administration comprising a matrix containing a viscosity modifier and coated granules containing hydromorphone. The dosage form can have a release profile such that 16 hours following administration, less than about 85 percent of the hydromorphone is released. In addition, the dosage form may have alcohol and/or crush resistance.
    Type: Application
    Filed: June 5, 2014
    Publication date: October 2, 2014
    Inventors: Ehab Hamed, Manuel A. Vega Zepeda
  • Abuse resistant drug formulation
    Patent number: 8445018
    Abstract: A pharmaceutical composition may include a coated particulate which may include at least one active pharmaceutical ingredient, particularly one susceptible to abuse by an individual. The coated particles may include a fat/wax and have improved controlled release and/or crush resistance. Method of making these coated particulate and dosage forms therewith are also described.
    Type: Grant
    Filed: March 12, 2008
    Date of Patent: May 21, 2013
    Assignee: Cima Labs Inc.
    Inventors: Walid A. Habib, Ehab Hamed, Manuel A. Vega Zepeda
  • Abuse-Resistant Formulations
    Publication number: 20120225122
    Abstract: This disclosure relates to a sustained-release oral dosage form for once-a-day administration comprising a matrix containing a viscosity modifier and coated granules containing hydromorphone. The dosage form can have a release profile such that 16 hours following administration, less than about 85 percent of the hydromorphone is released. In addition, the dosage form may have alcohol and/or crush resistance.
    Type: Application
    Filed: May 14, 2012
    Publication date: September 6, 2012
    Applicant: CIMA LABS INC.
    Inventors: Ehab HAMED, Manuel A. VEGA ZEPEDA
  • Abuse resistant drug formulation
    Publication number: 20080311205
    Abstract: A pharmaceutical composition may include a coated particulate which may include at least one active pharmaceutical ingredient, particularly one susceptible to abuse by an individual. The coated particles may include a fat/wax and have improved controlled release and/or crush resistance. Method of making these coated particulate and dosage forms therewith are also described.
    Type: Application
    Filed: March 12, 2008
    Publication date: December 18, 2008
    Applicant: CIMA LABS, Inc.
    Inventors: Walid A. Habib, Ehab Hamed, Manuel A. Vega Zepeda